《大行報告》高盛升李寧(02331.HK)目標價至31.6元 看好中國體育用品企業前景
高盛發表報告表示,重申看好中國體育用品企業前景,從近期數據顯示營運復甦,未來具多種推動力支持增長,包括中國政府支持政策、增加體育的參與、更佳的設計及功能產品提升需求,於2020年迎來東京奧運及2022年北京冬季奧運會,可令李寧(02331.HK)提升在國際品牌的市場份額。
該行相信,李寧在行業具良好佈局以提升市佔率,維持對其「買入」投資評級,上調對其目標價由24元升至31.6元,此相當預測2024財年市盈率22倍,並調高對其2019至2021財年純利預測1至9%,基於銷售及毛利表現較佳。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.